Immunos Therapeutics Ag is located in Schlieren, Switzerland on Wagistrasse 14. Immunos Therapeutics Ag is rated 5 out of 5 in the category biotechnology in Switzerland. Immunos Therapeutics AG is developing the next generation of immunotherapies that have a role in the innate immune system for cancer. The company is developing therapies that not only have direct anti-tumor effects but also remodel the tumor microenvironment to enhance the efficacy of existing immunotherapies. This industry leading portfolio of next generation, novel immunomodulatory proteins target diverse and key immunoregulatory receptors and exhibit strong anti-tumor responses in multiple cancers with monotherapy and in combination with checkpoint inhibitors (CTLA-4, PD-1, PD-L1) and costimulatory agonists (e.g. 4-1BB).
Company size
1-10 employees
Headquarters
Schlieren, Zurich
Accessibility
Wheelchair-accessible entrance